|
|||||
|
|
An in vivo drug repurposing screen and transcriptional analyses reveals the serotonin pathway and GSK3 as major therapeutic targets for NGLY1 deficiency |
|
| Authors: | Kevin A. Hope Alexys R. Berman Randall T. Peterson Clement Y. Chow |
| Affiliation: | 1. Department of Human Genetics, University of Utah School of Medicine, Salt Lake City, Utah, United States of America;2. College of Pharmacy, University of Utah, Salt Lake City, Utah, United States of America; Pennsylvania State University, UNITED STATES |
| Abstract: | |
| Keywords: | |